Unusual aetiology of isolated lower motor neuron facial palsy: Systemic lupus erythematosus presenting with cranial nerve palsy and nephritis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Kazzaz, Nayef Mohammed ^a   El Rifai, Rasha ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN M ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; STEROID; UREA; VALACICLOVIR; VIRUS ANTIBODY; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; DRUG DERIVATIVE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BELL PALSY; CASE REPORT; COMMON COLD; COMPLEMENT BLOOD LEVEL; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; FEVER; HEMATURIA; HUMAN; INDUCTION CHEMOTHERAPY; IRON DEFICIENCY ANEMIA; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MYALGIA; PHYSICAL EXAMINATION; PLEURISY; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINALYSIS; ANALOGS AND DERIVATIVES; COMPLICATION; FACIAL PARALYSIS; LUPUS NEPHRITIS; YOUNG ADULT;

ADRENAL CORTEX HORMONES; FACIAL PARALYSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MYCOPHENOLIC ACID; PROTEINURIA; YOUNG ADULT;

EID: 84885439778     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-200378     Document Type: Article

References (9)

1. Gupta DK, Atam V, Chaudhary SC. Recurrent lower motor neuron type facial palsy: an unusual manifestation of SLE. BMJ Case Rep. Published Online: 2 Feb 2011 doi:10.1136/bcr.12.2010.3564
2. Ginzler E, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219-28. (Pubitemid 41697285)
3. Saleh Z, Menassa J, Abbas O, et al. Cranial nerve VI palsy as a rare initial presentation of systemic lupus erythematosus: case report and review of the literature. Lupus 2010;19:201-5.
4. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-69.
5. Florica B, Aghdassi E, Su J, et al. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2011;41:203-11.
6. Tola MR, Granieri E, Caniatti L, et al. Systemic lupus erythematosus presenting with neurological disorders. J Neurol 1992;239:61-4.
7. Gerl V, Lischka A, Panne D, et al. SO Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. AU Ann Rheum Dis 2010;69:1370.
8. Liang MH, Corzillius M, Bae S-C, et al. The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes. Arthritis Rheum 42:599-608.
9. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with nesuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074-82.